FDA OKs Safety Warning Update for Menopause Hormone Therapies

(MedPage Today) — The FDA on Thursday approved label changes for six hormone replacement therapies (HRTs) that remove boxed warnings for cardiovascular disease, breast cancer, and probable dementia.
For more than two decades, the boxed warnings…

Source link : https://www.medpagetoday.com/obgyn/hrt/119887

Author :

Publish date : 2026-02-13 20:49:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

FDA OKs Safety Warning Update for Menopause Hormone Therapies

Aspirin Tied to 29% Lower Rate of Life-Threatening Pregnancy Complication in Study

Prior Ibrutinib May Improve CAR-T Efficacy in Rare Lymphoma

Related Posts

FDA Signals Regulatory Flexibility With Accelerated Approval of Rare Disease Drug

From Hospital Janitor to Doctor; More Medical Misogyny; High-Noon Showdown in the OR

Here’s What People Want on ‘The Pitt’ Season 3

In the Hot Seat at ACC: PE Clot-Buster, Impella-Protected PCI, Utility of CAC=0

Dupilumab May Simplify Chronic Spontaneous Urticaria Treatment

First glimpse of sperm whale birth reveals teamwork to support newborn

FDA Signals Regulatory Flexibility With Accelerated Approval of Rare Disease Drug

From Hospital Janitor to Doctor; More Medical Misogyny; High-Noon Showdown in the OR

Here’s What People Want on ‘The Pitt’ Season 3

In the Hot Seat at ACC: PE Clot-Buster, Impella-Protected PCI, Utility of CAC=0

Dupilumab May Simplify Chronic Spontaneous Urticaria Treatment

First glimpse of sperm whale birth reveals teamwork to support newborn

Bedside Classification of ARDS Subtype May Help Spot Patients With Higher Death Risk

Anti-VEGF Injections Safe Around CVD Events

Categories

Archives